NEWS
News Articles
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Phase 2b clinical trial in collaboration with Professor Shabir Madhi and Wits UniversityBill & Melinda Gates Foundation providing $15 million grant toward trialMature trial infrastructure along with significant levels of seasonal transmission may allow for rapid efficacy evaluation Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the beginning of a Phase 2b…
Read MoreNominate Your Company to be the Buzz of BIO
Enter to Win a Free BIO IMPACT Digital Company Presentation and Registration (Valued at $600) At BIO IMPACT Digital, we are celebrating the innovators and risk-takers making an impact on our world, developing game-changing products, technologies and solutions solving societal challenges. Are you an innovative biotech company developing a ground-breaking product or new technology within…
Read MoreEmory University, Grady Health, Children’s Healthcare among Georgia sites in Phase III of Covid-19 vaccine trial
Emory University and four other sites in the Atlanta area and Savannah are taking part in the large-scale Phase III of a national clinical trial for experimental Covid-19 vaccine mRNA-1273. Emory administered the first dose of the investigational vaccine at the Hope Clinic of Emory Vaccine Center this week. Hundreds of adult volunteers 18 and…
Read MoreUS government strikes $1.525 billion deal with Moderna for 100 million doses of its Covid-19 vaccine
The Trump administration has reached a deal with Moderna Inc. to manufacture and deliver 100 million doses of the company’s Covid-19 vaccine once it is approved, according to a news release from the US Health and Human Services Department. President Trump announced the deal during a media briefing on Tuesday. Moderna is one of several…
Read MorePortable UV Disinfection Chambers Could Help Address PPE Shortage
Portable disinfection chambers that use ultraviolet (UV) light to inactivate virus particles could allow emergency medical technicians, police officers, healthcare workers, pharmacy technicians, and others to quickly disinfect their personal protective equipment (PPE) as they need it. Researchers at the Georgia Tech Research Institute (GTRI) have built two prototype chambers to evaluate PPE disinfection using different sources…
Read MoreTakeda teams up with Novavax to introduce its coronavirus vaccine in Japan
Takeda now has a vaccine project in its fight against the COVID-19 pandemic, alongside repurposing existing drugs and developing a plasma-based therapy to treat the deadly disease. The Japanese pharma reached a deal with Novavax to develop, manufacture and sell the U.S. biotech’s coronavirus vaccine candidate, NVX-CoV2373, in Japan. While the exact monetary terms were not disclosed, the pair…
Read More